SFA for Pharma
Pharmaceutical field sales operates under constraints that most other industries don’t face. Regulatory compliance, sample management, doctor relationship tracking, and chemist coverage all require SFA capabilities that go well beyond basic order capture.
The productivity opportunity is real. Clarivate’s survey of physicians found that doctors average just 11 minutes per pharma rep visit - and the average rep visits only 3 doctors per day, with 10–15 minutes of wait time per visit plus significant commute between clinics. That means a large portion of an MR’s working day is unproductive travel and waiting. SFA is the infrastructure that reclaims it.
The Pharma Field Sales Structure
Section titled “The Pharma Field Sales Structure”A typical pharma field sales operation has two distinct tracks that SFA must support simultaneously:
Medical Rep (MR) → Doctor calls
- Scheduled visits to doctors, specialists, and hospitals
- Sample distribution with sign-off and compliance tracking
- Detailing sessions presenting clinical data
- Relationship management over a long prescribing cycle
MR → Chemist/Pharmacy coverage
- Ensuring product availability at chemists near target doctors
- Checking prescription fulfilment rates
- Capturing secondary sales data
- Managing stockouts and near-expiry products
Most pharma SFA implementations fail because they try to handle both tracks with a single workflow designed for only one of them.
Compliance-First Design
Section titled “Compliance-First Design”In pharma, compliance shapes every SFA requirement.
Sample Management
Section titled “Sample Management”Sample distribution is heavily regulated in most markets. SFA must:
- Track sample inventory issued to each rep at the beginning of the period
- Record sample hand-offs with doctor signature (digital or physical)
- Generate sample reconciliation reports (issued vs. distributed vs. remaining)
- Flag discrepancies for manager review
- Maintain an audit trail for regulatory inspection
A rep who cannot account for samples is a compliance liability. SFA that handles sample management properly is not a nice-to-have in pharma - it is mandatory.
Call Reporting
Section titled “Call Reporting”Every doctor visit must be documented. Research by Clarivate found physicians average just 11 minutes per rep interaction - which means call reports that take more than 2 minutes to complete will be filled in retrospectively and inaccurately. SFA design matters: the form should be fast, structured, and require minimal free-text typing.
SFA should capture:
- Doctor visited (from pre-defined list or new additions)
- Products detailed (which brands discussed)
- Samples left (quantity and batch number)
- Doctor feedback and objections
- Next call objectives
SOB (Specialty of Business) Tracking
Section titled “SOB (Specialty of Business) Tracking”Different products target different doctor specialties. SFA should allow managers to track:
- Which specialties are being covered vs. target coverage
- Which doctors in each specialty are being visited at target frequency
- Which doctors have lapsed (not visited in 60+ days)
Doctor Universe Management
Section titled “Doctor Universe Management”The doctor database is the pharma equivalent of the FMCG outlet universe. Fierce Healthcare surveys show 31% of physician practices are never visited by pharma reps - meaning significant commercial opportunity is being left unaddressed simply because it’s not mapped in the system.
A clean doctor database in SFA includes:
- Specialties and sub-specialties: not all cardiologists are the same target
- Prescription potential: high, medium, low prescribers of your category
- Hospital affiliations: which hospitals a doctor is attached to
- Visit frequency targets: A doctors monthly, B doctors bi-monthly, C doctors quarterly
- Contact preferences: some doctors only see reps on specific days
Doctor data goes stale fast. Doctors relocate, retire, change specialties, or switch hospitals. SFA should have a process for reps to flag changes, and someone must own keeping the database current.
Chemist Coverage Integration
Section titled “Chemist Coverage Integration”The chemist layer is where prescriptions become sales. Fierce Healthcare research shows that nearly 50% of multi-physician practices receive pharma rep visits every week - but if product isn’t available at the chemists near those doctors, the detailing investment is wasted.
SFA should enable:
- Chemist universe management: all chemists near target doctors, with tier classification
- Stock availability checks: rep confirms product is on shelf during the visit
- Near-expiry tracking: rep records products close to expiry for return or replacement
- Prescription fill rate: tracking how many prescriptions written by target doctors are being filled at covered chemists
KPIs for Pharma SFA
Section titled “KPIs for Pharma SFA”| KPI | What It Measures |
|---|---|
| Doctor coverage | % of target doctors visited in the period |
| Call average | Average doctor calls per rep per day |
| Coverage quality | % of A-class doctors visited at target frequency |
| Sample compliance | % of sample distributions with complete sign-off |
| Chemist availability | % of chemists with product in stock |
| Lapsed doctors | % of target doctors not visited in 60+ days |
| New doctor additions | Doctors added to universe by reps in the field |
Territory Design Considerations
Section titled “Territory Design Considerations”Pharma territory design is different from FMCG. Reps don’t follow fixed routes - they work around doctor availability, clinic hours, and hospital visiting schedules.
SFA should support:
- Flexible daily planning: rep plans the day based on doctor availability, not a fixed sequence
- Call scheduling: ability to book doctor visits in advance and receive reminders
- Hospital visit tracking: separate workflow for hospital calls (multiple doctors in one building)
- Joint field work: when a manager accompanies a rep, both activities are logged
Common Pharma Implementation Mistakes
Section titled “Common Pharma Implementation Mistakes”Replicating paper call reports digitally. Most pharma companies have 2-page paper call reports designed for administrative compliance, not operational insight. Moving these forms into SFA verbatim creates a slow, painful workflow. Redesign the call report for speed first, compliance second.
Ignoring the chemist layer. Many pharma SFA implementations focus entirely on doctor detailing and skip chemist coverage tracking. This creates a blind spot: you know which doctors were visited, but not whether the prescriptions written are being filled.
Not integrating with stockist/distributor data. Pharma distribution goes company → stockist → chemist. Without stockist integration, you have no visibility into whether product is available when chemists need to fill prescriptions.
Treating all doctors equally. A doctor who writes 50 prescriptions per month for your category and a doctor who writes 2 need different call frequencies, different sample quantities, and different detailing approaches. SFA that doesn’t support doctor tiering results in reps optimising for visit counts rather than business impact.
Regulatory Reporting from SFA Data
Section titled “Regulatory Reporting from SFA Data”One underutilised benefit of pharma SFA: the data it generates is exactly what regulators ask for.
Sample distribution audits, doctor call records, and rep activity logs are typically required for pharma compliance in most markets. Companies that run SFA well can generate regulatory reports in hours. Companies that don’t recreate data from memory and paper when inspections happen.
This is a strong internal argument for SFA investment in pharma: it’s not just a sales productivity tool - it’s your compliance infrastructure.